|
|
|
|
LEADER |
01938nam a2200229 a 4500 |
001 |
1742781 |
005 |
20171111234453.0 |
008 |
110531s2012 enka sb 001 0 eng d |
020 |
|
|
|z 9780470657348 (cloth)
|
040 |
|
|
|a CaPaEBR
|z 9781119959571 (e-book)
|
050 |
1 |
4 |
|a RM301.3.G45
|b P4235 2012eb
|
245 |
0 |
0 |
|a Pharmacogenomics in clinical therapeutics
|c edited by Loralie J. Langman, Amitava Dasgupta.
|
260 |
|
|
|a Chichester, West Sussex, U.K. :
|b Wiley-Blackwell,
|c 2012.
|
300 |
|
|
|a ix, 244 p. :
|b ill.
|
500 |
|
|
|a Two columns to the page.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Pharmacogenomics principles : introduction to personalized medicine / Parvaz Madadi, and Gideon Koren -- Traditional therapeutic drug monitoring and pharmacogenomics : are they complementary? / Christine Snozek, Loralie J. Langman, and Amitava Dasgupta -- Pharmacogenomics aspect of warfarin therapy / Matthew D. Krasowski -- Pharmacogenetics and cancer chemotherapy / Christine L.H. Snozek -- Pharmacogenomic considerations in anesthesia and pain management / Christine Formea, Wayne T. Nicholson -- Pharmacogenomics of immunosuppressants / Nicolas Picard and Pierre Marquet -- Pharmacogenomics of cardiovascular drugs / Linnea M. Baudhuin -- Pharmacogenomics aspect of antiretroviral therapy / Natella Y. Rakhmanina and John N. van den Anker -- Pharmacogenetics of psychoactive drugs / Jorge L. Sepulveda -- Pharmacogenomic aspects of adverse drug-drug interactions / Loralie J. Langman and Christine Snozek -- Microarray technology and other methods in pharmacogenomics testing / Jorge L. Sepulveda -- Pharmacogenetic testing in the clinical laboratory environment / Mark P. Borgman and Mark W. Linder.
|
650 |
|
0 |
|a Pharmacogenetics.
|
700 |
1 |
|
|a Langman, Loralie J.
|
710 |
2 |
|
|a ebrary, Inc.
|
856 |
4 |
0 |
|u http://site.ebrary.com/lib/ucy/Doc?id=10531480
|
952 |
|
|
|a CY-NiOUC
|b 5a04514c6c5ad14ac1ec4053
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|